About David Wheadon
Form D filings for Seaport Therapeutics in 2024 list David Wheadon as director.
David Wheadon first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name David Wheadon in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Wheadon works with at each company, as listed on that company's latest Form D.
Seaport Therapeutics, Inc. · Form D, Oct 31, 2024
JH
James Healy
Director
MC
Michael Chen
Executive officer
LG
Lana Gladstein
General Counsel
DZ
Daphne Zohar
Executive officer and director
AL
Antony Loebel
Executive officer
EG
Eric Green
Executive officer
RN
Robert Nelsen
Director
SP
Steven Paul
Director
BC
Bharatt Chowrira
Director
DT
Denice Torres
Director
EE
Eric Elenko
Director
JP
Jason Pitts
Director